Cyteir Therapeutics Inc
Biotechnology
Healthcare
CYT
35.74 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
3.04
52 week high
3.13
high
3.05
52 week low
1.32
low
3.01
growth
72.57 %
previous Close
3.04
P/E ratio
market cap
99.35 M
div yield
0
usd
Sep 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top